Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02475200 · ClinicalTrials.gov registry record
Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems
A clinical trial, sponsored by Volcano Corporation.
- Completed
- Registry status
- 500
- Enrollment target
NCT02475200: Completed study, sponsored by Volcano Corporation.
NCT02475200 is a clinical trial that has completed, run by Volcano Corporation. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02475200 has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The Phoenix Post-Approval Registry is a prospective, multi-center, single arm registry sponsored by Volcano Corporation to evaluate the short and long term performance and clinical outcomes of the Phoenix Atherectomy System.
Primary Outcome
Rates of TECHNICAL SUCCESS (ratio of Phoenix treated lesions with \<=50% residual diameter stenosis to all Phoenix treated lesions); and PROCEDURAL SUCCESS (ratio of target lesion residual stenosis of \<=30% after treatment with Phoenix and adjunctive treatments to all treated lesions)
Interventions
- DEVICE Atherectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2015-09-14 |
| Est. Completion | 2020-05-29 |
What the finished NCT02475200 record still lists
NCT02475200 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Atherectomy is the first listed.
NCT02475200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02475200 about?
NCT02475200 is a clinical study titled "Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems". The Phoenix Post-Approval Registry is a prospective, multi-center, single arm registry sponsored by Volcano Corporation to evaluate the short and long term performance and clinical outcomes of the Phoenix Atherectomy System.
What is the current status of trial NCT02475200?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2015-09-14. Estimated completion is 2020-05-29.
What interventions are being tested in trial NCT02475200?
The interventions under investigation include: Atherectomy (DEVICE).
Who is sponsoring clinical trial NCT02475200?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI